Viewing Study NCT04246866


Ignite Creation Date: 2025-12-24 @ 4:14 PM
Ignite Modification Date: 2026-01-04 @ 11:59 PM
Study NCT ID: NCT04246866
Status: COMPLETED
Last Update Posted: 2021-02-11
First Post: 2020-01-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration
Sponsor: Gemini Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module